Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ATAI
#2227
AtaiBeckley Inc. - Common Stock
3.8
4
USD
-2.04%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-2.04%
Monthly Change
-10.90%
6 month change
-2.78%
Year Change
-2.78%
Previous Close
3.9
2
Open
3.8
4
Low
3.8
4
High
3.8
4
Volume
81
Markets
US Stock Market
Healthcare
ATAI
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2025
Current
Key stats
Total common shares outstanding
364.75 M
368.17 M
Valuation ratios
Enterprise value
1.41 B
1.41 B
Price to earnings ratio
-1.41
—
Price to sales ratio
226.59
—
Price to cash flow ratio
-9.02
—
Price to book ratio
4.18
—
Enterprise value to EBITDA ratio
-2.19
—
Profitability ratios
Return on assets %
-2.25
-0.11
Return on equity %
-2.97
-0.15
Return on invested capital %
-1 368.42
-63.51
Gross margin %
100
100
Operating margin %
-15.75 K
-3 239.1
EBITDA margin %
-15.73 K
-3 221.59
Net margin %
-16.14 K
-3 121.8
Liquidity ratios
Quick ratio
—
—
Current ratio
11.74
10.02
Inventory turnover
—
—
Asset turnover
0.01
0
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
0
—
Long term debt to total equity ratio
0
—
Per share metrics
Operating cash flow per share
-0.45
—
EBIT per share
-2.84
—
EBITDA per share
-2.84
—
Total debt per share
—
—
Cash per share
0.38
0.12
Net current asset value per share
1.22
0.7
Tangible book value per share
0.97
0.56
Working capital per share
1.11
0.63
Book value per share
0.98
0.56
News
COMPASS Pathways: A Psychedelics Story (NASDAQ:CMPS)
Trump's Psychedelics Stance Reignites Sector - How Investors Can Benefit
Fresh Middle East Strains Drag on Stocks
Save This Psychedelic Stock Watchlist After Trump’s Latest Executive Order
Market Feels Weak, But Stocks Tell Stories
Psychedelic stocks rally with Trump’s support
Definium: 'Strong Buy' Maintained On Several Anticipated 2026 Milestones (NASDAQ:DFTX)
AtaiBeckley: 'Buy' On New Key Developments For BPL-003 For TRD (NASDAQ:ATAI)
AtaiBeckley publishes Phase 2a data for depression treatment
H.C. Wainwright reiterates atai Life Sciences stock rating at buy
AtaiBeckley plans Phase 3 trials for depression treatment in Q2
AtaiBeckley Inc. (ATAI) Analyst/Investor Day - Slideshow (NASDAQ:ATAI) 2026-03-07